Cost-utility of a Progressive Spacing of Tocilizumab or Abatacept in Patients with Rheumatoid Arthritis in Sustained Remission: A Medicoeconomic Analysis of the Towards the Lowest Efficacious Dose Trial

被引：0
|
作者：
Kedra, Joanna [1 ,2 ]
Granger, Benjamin [2 ,3 ]
El Houari, Lina [4 ]
Tubach, Florence [5 ]
Fautrel, Bruno [6 ]
机构：
[1] Sorbonne Univ, IPLESP, Paris, France
[2] Hop La Pitie Salpetriere, Paris, France
[3] Sorbonne Univ, INSERM, Paris, France
[4] Inst Pierre Louis Epidemiol & Sante Publ, Paris, France
[5] APHP, Ctr Pharm Epidemiol, Paris, France
[6] Sorbonne Univ, APHP, Paris, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2169
引用
收藏
页码：4285 / 4286
页数：2
相关论文
共 50 条
  • [1] COST-UTILITY OF A PROGRESSIVE SPACING OF TOCILIZUMAB OR ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS IN SUSTAINED REMISSION: A MEDICO-ECONOMIC ANALYSIS OF THE TOLEDO TRIAL
    Kedra, J.
    Granger, B.
    El Houari, L.
    Tubach, F.
    Fautrel, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 174 - 175
  • [2] Cost-Effectiveness of a Progressive Spacing of Tocilizumab or Abatacept in Patients with Rheumatoid Arthritis in Sustained Remission: A Medico-Economic Analysis of the ToLEDo Trial
    Kedra, Joanna
    El Houari, Lina
    Tubach, Florence
    granger, Benjamin
    Fautrel, Bruno
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2806 - 2807
  • [3] Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission
    Kedra, Joanna
    Dieude, Philippe
    Giboin, Caroline
    Marotte, Hubert
    Salliot, Carine
    Schaeverbeke, Thierry
    Perdriger, Aleth
    Soubrier, Martin
    Morel, Jacques
    Constantin, Arnaud
    Dernis, Emmanuelle
    Royant, Valerie
    Salmon, Jean-Hugues
    Pham, Thao
    Gottenberg, Jacques-Eric
    Pertuiset, Edouard
    Dougados, Maxime
    Devauchelle-Pensec, Valerie
    Gaudin, Philippe
    Cormier, Gregoire
    Goupille, Philippe
    Mariette, Xavier
    Berenbaum, Francis
    Alcaix, Didier
    Rouidi, Sid-Ahmed
    Berthelot, Jean-Marie
    Monnier, Agnes
    Piroth, Christine
    Liote, Frederic
    Goeb, Vincent
    Gaujoux-Viala, Cecile
    Chary-Valckenaere, Isabelle
    Hajage, David
    Tubach, Florence
    Fautrel, Bruno
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (04) : 541 - 552
  • [4] Towards the Lowest Efficacious Dose (ToLEDo): Results of a Multicenter Non-Inferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis Patients in Remission
    Kedra, Joanna
    Dieude, Philippe
    Marotte, Hubert
    Lafourcade, Alexandre
    Ducourau, Emilie
    Schaeverbeke, Thierry
    Perdriger, Aleth
    Soubrier, Martin
    Morel, Jacques
    Constantin, Arnaud
    Dernis, Emmanuelle
    Royant, Valerie
    Salmon, Jean-Hugues
    Pham, Thao
    Gottenberg, Jacques-Eric
    Pertuiset, Edouard
    Dougados, Maxime
    Pensec, Valerie Devauchelle
    Gaudin, Philippe
    Cormier, Gregoire
    Goupille, Philippe
    Mariette, Xavier
    Berenbaum, Francis
    Alcaix, Didier
    Rouidi, Sid-Ahmed
    Berthelot, Jean-Marie
    Monnier, Agnes
    Piroth, Christine
    Liote, Frederic
    Goeb, Vincent
    Gaujoux-Viala, Cecile
    Chary-Valckenaere, Isabelle
    Hajage, David
    Tubach, Florence
    Fautrel, Bruno
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [5] TOWARDS THE LOWEST EFFICACIOUS DOSE (TOLEDO): RESULTS OF A MULTICENTER NON-INFERIORITY RANDOMIZED OPEN-LABEL CONTROLLED TRIAL ASSESSING TOCILIZUMAB OR ABATACEPT INJECTION SPACING IN RHEUMATOID ARTHRITIS PATIENTS IN REMISSION
    Kedra, Joanna
    Dieude, Philippe
    Marotte, Hubert
    Lafourcade, Alexandre
    Ducourau, Emilie
    Schaeverbeke, Thierry
    Perdriger, Aleth
    Soubrier, Martin
    Morel, Jacques
    Constantin, Arnaud
    Dernis, Emmanuelle
    Royant, Valerie
    Salmon, Jean-Hugues
    Thao Pham
    Gottenberg, Jacques-Eric
    Pertuiset, Edouard
    Dougados, Maxime
    Devauchelle-Pensec, Valerie
    Gaudin, Philippe
    Cormier, Gregoire
    Goupille, Philippe
    Mariette, Xavier
    Berenbaum, Francis
    Alcaix, Didier
    Rouidi, Sid Ahmed
    Berthelot, Jean-Marie
    Monnier, Agnes
    Piroth, Christine
    Liote, Frederic
    Goeb, Vincent
    Gaujoux-Viala, Cecile
    Valckenaere, Isabelle Chary
    Hajage, David
    Tubach, Florence
    Fautrel, Bruno
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 715 - 716
  • [6] Cost-utility analysis of abatacept in rheumatoid arthritis in Italy
    de Portu, Simona
    Mantovani, Lorenzo Giovanni
    Olivieri, Ignazio
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2008, 9 (01) : 19 - 26
  • [7] TARGETING THE LOWEST EFFICACIOUS DOSE FOR RHEUMATOID ARTHRITIS PATIENTS IN REMISSION: CLINICAL AND STRUCTURAL IMPACT OF A STEP-DOWN STRATEGY TRIAL BASED ON PROGRESSIVE SPACING OF TNF-BLOCKER INJECTIONS (STRASS TRIAL)
    Fautrel, B.
    Gandjbakhch, F.
    Foltz, V.
    Pham, T.
    Morel, J.
    Alfaiate, T.
    Demis, E.
    Gaudin, P.
    Mariette, X.
    Tubach, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 72 - 72
  • [8] STEP-DOWN STRATEGY OF SPACING TNF-BLOCKERS INJECTIONS FOR ESTABLISHED RHEUMATOID ARTHRITIS IN REMISSION: A COST-UTILITY ANALYSIS BASED ON THE STRASS TRIAL
    Vanier, A.
    Tubach, F.
    Alfaiate, T.
    Mariette, X.
    Fautrel, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 178 - 178
  • [9] COST-UTILITY ANALYSIS OF TOCILIZUMAB IN COMBINATION WITH METHOTREXATE VERSUS STANDARD OF CARE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN GREECE
    Athanasakis, K.
    Konstantopoulou, T.
    Tarantilis, F.
    Tsalapati, K.
    Vritzali, E.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2013, 16 (07) : A565 - A565
  • [10] Step-Down Strategy of Spacing TNF-Blockers Injections for Established Rheumatoid Arthritis in Remission: A within Randomized Control Trial Based Cost-Utility Analysis
    Vanier, Antoine
    Tubach, Florence
    Alfaiate, Toni
    Mariette, Xavier
    Fautrel, Bruno
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345